Back
Protagonist Therapeutics Vs. Exicure Industry Stock Comparison
Sell
41
PTGX
Protagonist Therapeutics
Last Price:
44.91
Seasonality Move:
11.46%
Buy
62
XCUR
Exicure
Last Price:
30.86
Seasonality Move:
-4.03%
Sell
41
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $44.95. The Score for PTGX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Exicure (XCUR)
is a Buy
Is Exicure a Buy, Sell or Hold?
- The current Exicure [XCUR] share price is $31.99. The Score for XCUR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- XCUR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $44.95
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
XCUR Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 52.11 | Buy |
| Chaikin Money Flow: | 158201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.11 - 47.71) | Buy |
| Bollinger Bands (100): | (38.82 - 46.4) | Buy |
XCUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.9 | Buy |
| Relative Strength Index (14 RSI): | 95.88 | Buy |
| Chaikin Money Flow: | 80777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-1.39 - 16.11) | Buy |
| Bollinger Bands (100): | (-1.28 - 8.54) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.89 | Buy |
| 20-day SMA: | 44.21 | Buy |
| 50-day SMA: | 45.19 | Sell |
| 200-day SMA: | 36.06 | Buy |
| 8-day EMA: | 43.96 | Buy |
| 20-day EMA: | 44.12 | Buy |
| 50-day EMA: | 44.14 | Buy |
| 200-day EMA: | 37.12 | Buy |
XCUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.08 | Buy |
| 20-day SMA: | 8.58 | Buy |
| 50-day SMA: | 5.2 | Buy |
| 200-day SMA: | 3.1 | Buy |
| 8-day EMA: | 19.83 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 6.88 | Buy |
| 200-day EMA: | 3.97 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.
Exicure Earnings Growth & XCUR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exicure Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||